All Type of News
Baraclude taken out from Seoul National University Hospital’s internal code list
A BMS Korea’s hepatitis treatment, Baraclude has finally been taken out from the internal code list of Seoul National University Hospital.
According to the industry concerned on the 21st, one of the Seoul National U...
“If others are obeying CP, the effect of illegal rebates get double or triple”
“There are some companies criticizing (such as illegal rebates) in the front, while having rebate activities in the back. Is it because the effect of illegal rebates become even larger while other competing companies ...
‘Domestic rare disease treatments’ grew as leading products
Pricey rare disease treatments have grown as leading products of domestic pharmaceutical companies.
Since they are expensive as essential drugs despite the small number of patients needing them, their sales have been...
Weigh-losing antidiabetic ‘Jardiance’ passed wall of the health insurance
A weight-losing antidiabetic ‘Jardiance’ will receive the health insurance benefits.
According to the industry concerned on the 18th, Boehringer Ingelheim and Lilly has recently made an agreement for the price of Jar...
Handok-Teva acquires commercialization approval for Symbicort genericA competitor against an AstraZeneca’s asthma and COPD drug recording annual KRW 10 billion sales, ‘Symbicort Turbuhaler(budesonide/formoterol),’ emerged.
As Handok-Teve succee...
|
Insurance benefit of Baraclude extended to children over 2A BMS Korea’s hepatitis B treatment, ‘Baraclude’ will be extended in the health insurance benefit to children over 2. Moreover, a Boehringer Ingelheim’s chronic obstructive pulm...
|
One of three listed pharmaceutical companies spent over 40% of sales into sales management expenses
One of three listed pharmaceutical companies were aggregated to spend 40% of their sales on sales management expenses. In order to raise profits, pharmaceutical companies have been working on reducing the fees, but it...
“Korean pharmaceutical companies have high chances to succeed in Russia”
President Alexey Repik(39) of the Russia’s top pharmaceutical company, R-PHARM, took a 4-day trip to Korea for 4 days from the 4th to 7th.
During the trip, he had in-depth discussions about creation of business model...
NHIS recorded largest collective surplus of KRW 17 trillion
Managed by the National Health Insurance Corporation(NHIS), the National Health Insurance budget is reaching for collective KRW 17 trillion gains.
According to the data provided by the 1st NHIS Regular Board Meeting ...
“Insurance benefits for conscious sedation endoscopy?”
The government announced plans to provide the insurance benefit for conscious sedation endoscopy targeting patients suffering from the 4 severe diseases within this year, and is getting ready for them.
On the 14th, ...
